Video

Reengineering HSV: Next-Gen Oncolytic and Gene Delivery Vectors in Oncology

Source: Cell & Gene

In this segment of Cell & Gene Live, Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More, Francesca Barone, M.D., Ph.D., CSO at Candel Therapeutics explains how next-generation HSV-based platforms are overcoming past limitations in oncolytic viral therapy and gene delivery.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)